• 1. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller
• 2. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 3. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 4. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 5. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzopyrazoles Indazoles

Research Brief on 1-Acetyl-5-bromo-1H-indazole (CAS: 152626-92-1): Recent Advances and Applications in Chemical Biology and Medicine

1-Acetyl-5-bromo-1H-indazole (CAS: 152626-92-1) is a brominated indazole derivative that has garnered significant attention in recent years due to its versatile applications in medicinal chemistry and chemical biology. This compound serves as a key intermediate in the synthesis of various biologically active molecules, particularly in the development of kinase inhibitors and other therapeutic agents. Recent studies have explored its potential as a scaffold for drug discovery, leveraging its unique structural features to modulate protein-protein interactions and enzymatic activities.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the utility of 1-Acetyl-5-bromo-1H-indazole as a precursor in the synthesis of novel Bruton's tyrosine kinase (BTK) inhibitors. The researchers utilized palladium-catalyzed cross-coupling reactions to introduce diverse substituents at the 5-position, yielding compounds with improved selectivity and potency against BTK. This work highlights the compound's role in addressing the growing need for targeted therapies in autoimmune diseases and B-cell malignancies.

In the field of cancer research, a team from the University of Cambridge recently reported (Nature Chemical Biology, 2024) on the development of fluorescent probes derived from 1-Acetyl-5-bromo-1H-indazole for real-time imaging of apoptosis in tumor cells. The bromine atom at the 5-position proved crucial for the successful conjugation with fluorophores while maintaining the compound's ability to interact with caspase-3, a key apoptosis marker. This application opens new possibilities for non-invasive monitoring of therapeutic responses in preclinical models.

From a synthetic chemistry perspective, advances in the preparation of 1-Acetyl-5-bromo-1H-indazole have been achieved through improved bromination protocols. A 2023 publication in Organic Process Research & Development described a safer, more efficient method for the regioselective bromination of 1-acetylindazole using N-bromosuccinimide (NBS) in continuous flow reactors. This innovation addresses previous challenges in scale-up and reduces the environmental impact of the synthesis process.

The compound's mechanism of action continues to be elucidated through structural biology approaches. Recent X-ray crystallography studies (Acta Crystallographica Section D, 2024) have revealed how derivatives of 1-Acetyl-5-bromo-1H-indazole interact with the ATP-binding sites of various kinases. These structural insights are informing the design of next-generation inhibitors with enhanced specificity profiles, potentially reducing off-target effects in clinical applications.

Looking forward, 1-Acetyl-5-bromo-1H-indazole remains a promising scaffold for drug discovery, with several derivatives currently in preclinical development. Its versatility as a synthetic intermediate and the growing understanding of its biological interactions position this compound as a valuable tool in the chemical biology toolbox. Future research directions likely include exploration of its applications in PROTAC (proteolysis targeting chimera) technology and the development of covalent inhibitors targeting challenging therapeutic targets.

• 590417-97-3(5-Bromo-2-ethyl-2H-indazole)
• 13436-50-5(Ethanone,1-(2H-indazol-2-yl)-)
• 651780-33-5(1H-Indazole, 1-acetyl-6-bromo-)
• 61317-50-8(1H-Pyrazolo[3,4-f]quinoline, 1-acetyl-)
• 61317-48-4(3H-Pyrazolo[4,3-f]quinoline, 3-acetyl-)
• 13436-49-2(1-(1H-Indazol-1-yl)ethanone)
• 885698-70-4(1-Acetyl-4-bromo-1H-indazole)
• 590417-96-2(5-Bromo-1-ethylindazole)
• 633328-87-7(1H-Pyrazolo[4,3-c]pyridine, 1-acetyl- (9CI))
• 651780-46-0(1-(5-bromo-3-methyl-1H-indazol-1-yl)ethan-1-one)